Corcept Therapeutics
CORT
#2078
Rank
HK$70.62 B
Marketcap
HK$670.29
Share price
1.71%
Change (1 day)
44.97%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): HK$0.51 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are HK$0.74 Billion. In 2024 the company made an earning of HK$1.06 Billion, an increase over its 2023 earnings that were of HK$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.51 B-52.01%
2024 HK$1.06 B27.66%
2023 HK$0.83 B-4.75%
2022 HK$0.87 B-9.51%
2021 HK$0.96 B-2.91%
2020 HK$0.99 B14.87%
2019 HK$0.86 B24.71%
2018 HK$0.69 B69.32%
2017 HK$0.41 B419.26%
2016 HK$79.23 M-395.64%
2015 -HK$26.81 Million-87.53%
2014 -HK$0.22 Billion-33.44%
2013 -HK$0.33 Billion
2011 -HK$0.26 Billion17.84%
2010 -HK$0.22 Billion35.5%
2009 -HK$0.16 Billion2.84%
2008 -HK$0.16 Billion60.81%
2007 -HK$95.32 Million-52.14%
2006 -HK$0.2 Billion20.91%
2005 -HK$0.17 Billion31.87%
2004 -HK$0.13 Billion60.54%
2003 -HK$77.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$252.18 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.81 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$175.18 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.74 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.22 Billion-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.23 B-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA